| Literature DB >> 34772355 |
Wenlong Zheng1, Hui Zhang1, Dezheng Wang1, Chong Wang1, Shuang Zhang1, Chengfeng Shen1, Wei Li1, Guohong Jiang2,3.
Abstract
OBJECTIVE: Compare the urban-rural disparity in cancer mortality and changing trend during the past 18 years in Tianjin, China.Entities:
Keywords: Cancer; Cancer transition; Mortality; Trend
Mesh:
Year: 2021 PMID: 34772355 PMCID: PMC8590287 DOI: 10.1186/s12885-021-08907-0
Source DB: PubMed Journal: BMC Cancer ISSN: 1471-2407 Impact factor: 4.430
Fig. 1The male’s (a) and female’s (b) Cancer constituent ratios in the year 1999 and 2016 in Urban and Rural areas of Tianjin, China
The differences of cancer mortality rates (ASR) between urban and rural areas in Tianjin, China
| type | Urban(1/100000) | Rural(1/100000) | 1999 | 2016 | Na | Rb(%) | ||
|---|---|---|---|---|---|---|---|---|
| 1999 | 2016 | 1999 | 2016 | (U/R) | (U/R) | (person) | ||
| total | 125.7 | 99.6 | 71.5 | 90.0 | 1.76 | 1.11 | 33,739 | 40.1 |
| male | 151.6 | 119.1 | 91.1 | 107.5 | 1.66 | 1.11 | 20,770 | 42.6 |
| female | 99.8 | 80.0 | 57.6 | 73.4 | 1.73 | 1.09 | 12,969 | 36.5 |
| lung | 46.6 | 34.2 | 23.5 | 35.0 | 1.98 | 0.98 | 12,505 | 39.5 |
| liver | 15.9 | 9.8 | 11.6 | 10.3 | 1.37 | 0.95 | 1404 | 11.1 |
| stomach | 13.7 | 7.5 | 7.6 | 5.9 | 1.80 | 1.27 | 3513 | 50.7 |
| esophagus | 6.5 | 2.7 | 6.1 | 2.7 | 1.07 | 1.00 | 572 | 16.2 |
| colorectum | 7.9 | 8.7 | 3.6 | 5.6 | 2.19 | 1.55 | 3863 | 85.3 |
| pancreas | 5.2 | 5.2 | 1.7 | 4.4 | 3.06 | 1.18 | 1943 | 59.6 |
| leukemia | 3.6 | 2.7 | 3.2 | 3.6 | 1.13 | 0.75 | − 298 | −9.4 |
| brain and CNS | 3.3 | 2.6 | 3.0 | 3.5 | 1.10 | 0.74 | 150 | 4.9 |
| breast (female) | 6.8 | 8.0 | 3.3 | 4.8 | 2.06 | 1.67 | 1583 | 66.7 |
| lymphoma | 2.8 | 3.5 | 1.7 | 2.7 | 1.65 | 1.30 | 1102 | 54.1 |
| bladder | 2.3 | 1.9 | 1.2 | 1.9 | 1.92 | 1.00 | 444 | 40.2 |
| gallbladder | 1.3 | 2.9 | 0.4 | 2.0 | 3.25 | 1.45 | 1624 | 114.8 |
| Prostate | 1.3 | 3.1 | 0.8 | 1.9 | 1.63 | 1.63 | 2487 | 119.0 |
| Cervix | 1.8 | 2.5 | 1.4 | 2.1 | 1.29 | 1.19 | 372 | 19.3 |
| ovary | 0.3 | 3.8 | 0.0 | 2.1 | – | 1.81 | 4974 | 199.8 |
a“N” is the avoided death number of cancers in rural areas compare to urban death level
b“R” is the percentage of the avoided death number to the current death number of rural areas from 1999 to 2016
“U/R” = age standard mortality rate of urban areas/ age standard mortality rate of rural areas
The changing trend of cancers mortality from 1999 to 2016 in urban area of Tianjin, China
| type | AAPC(%) | trend 1 | trend 2 | ||
|---|---|---|---|---|---|
| years | APC(%) | years | APC(%) | ||
| total | − 1.20a(−1.7,-0.7) | 1999–2016 | − 1.20a(− 1.7,-0.7) | ||
| male | − 1.13a(− 1.6, -0.7) | 1999–2016 | −1.13a(− 1.6, -0.7) | ||
| female | −1.31a(− 1.8, -0.8) | 1999–2016 | − 1.31a(− 1.8, -0.8) | ||
| lung | − 1.43a(− 2.0, -0.9) | 1999–2016 | − 1.43a(− 2.0, -0.9) | ||
| liver | − 2.49a(− 3.0, −2.0) | 1999–2016 | -2.49a(− 3.0, -2.0) | ||
| stomach | −3.15a(− 3.7, -2.6) | 1999–2016 | −3.15a(− 3.7, -2.6) | ||
| esophagus | −5.02a(− 5.6, -4.4) | 1999–2016 | −5.02a(− 5.6, -4.4) | ||
| colorectum | 0.82a(0.3,1.3) | 1999–2016 | 0.82a(0.3,1.3) | ||
| pancreas | 0.27(− 0.5,1.1) | 1999–2016 | 0.27(− 0.5,1.1) | ||
| leukemia | −0.93a(−1.7,− 0.2) | 1999–2016 | -0.93a(− 1.7,-0.2) | ||
| brain and CNS | 0.17(− 1.2,1.6) | 1999–2016 | 0.17(− 1.2,1.6) | ||
| breast (female) | − 0.01(− 0.8,0.8) | 1999–2016 | − 0.01(− 0.8,0.8) | ||
| lymphoma | 1.58a(0.7,2.5) | 1999–2016 | 1.58a(0.7,2.5) | ||
| bladder | −2.52a(−3.6,-1.4) | 1999–2016 | − 2.52a(− 3.6,-1.4) | ||
| gallbladder | 2.11a(0.5,3.7) | 1999–2016 | 2.11a(0.5,3.7) | ||
| Prostate | 4.22a(2.7,5.4) | 1999–2016 | 4.22a(2.7,5.4) | ||
| Cervix | 2.3(−0.3,5.1) | 1999–2010 | −3.37a(−6.1,-0.6) | 2010–2016 | 13.65a(6.6,21.2) |
| ovary | 15.1a(8.6,22.0) | 1999–2003 | 71.75a(31.9123.6) | 2003–2016 | 1.75(−0.5,4.0) |
aThe AAPC or ACP has significantly different from zero (P < .05)
The changing trend of cancers mortality from 1999 to 2016 in rural area of Tianjin, China
| type | AAPC | trend 1 | trend 2 | trend3 | |||
|---|---|---|---|---|---|---|---|
| years | APC | years | APC | years | APC | ||
| total | 1.10a(0.1,2.1) | 1999–2004 | −0.99(−4.1,2.2) | 2004–2016 | 1.99a(1.2,2.8) | ||
| male | 1.00a(0.0,1.9) | 1999–2005 | −1.06(−3.4,1.4) | 2005–2016 | 2.10a(1.2,3.1) | ||
| female | 1.57a(1.1,2.1) | 1999–2016 | 1.57a(1.1,2.1) | ||||
| lung | 2.47a(1.8,3.1) | 1999–2016 | 2.47a(1.8,3.1) | ||||
| liver | −1.44a(−2.2, -0.7) | 1999–2016 | − 1.44a(− 2.2, -0.7) | ||||
| stomach | −1.46a(−2.0, -0.9) | 1999–2016 | − 1.46a(− 2.0, -0.9) | ||||
| esophagus | −4.40a(−6.1, -2.7) | 1999–2005 | −9.88a(−13.5, -6.2) | 2005–2016 | − 1.28(−3.2,0.7) | ||
| colorectum | 2.40a(1.1,3.6) | 1999–2004 | −1.20(−4.9,2.7) | 2004–2016 | 3.87a(2.9,4.8) | ||
| pancreas | 4.73a(3.8,5.6) | 1999–2016 | 4.73a(3.8,5.6) | ||||
| leukemia | 0.22(−0.5,0.9) | 1999–2016 | 0.22(−0.5,0.9) | ||||
| brain and CNS | 0.90a(−1.8,3.6) | 1999–2003 | −7.68(− 17.4,3.1) | 2003–2016 | 3.74a(1.9,5.5) | ||
| breast (female) | 2.76a(1.6,3.9) | 1999–2016 | 2.76a(1.6,3.9) | ||||
| lymphoma | 2.00(−1.6,5.8) | 1999–2005 | −8.78(− 14.7,-2.4) | 2005–2012 | 13.43a(6.7,20.6) | 2012–2016 | 0.25(−8.6,10.0) |
| bladder | 0.71(−1.3,2.8) | 1999–2016 | 0.71(− 1.3,2.8) | ||||
| gallbladder | 8.05a(6.3,9.8) | 1999–2016 | 8.05a(6.3,9.8) | ||||
| Prostate | 6.45a(4.1,8.9) | 1999–2016 | 6.45a(4.1,8.9) | ||||
| Cervix | 3.1(−0.9,7.2) | 1999–2008 | −4.2(−10.0,1.9) | 2008–2016 | 11.93a(5.4,18.9) | ||
| ovary | 10.7a(7.2,14.4) | 1999–2016 | 10.7a(7.2,14.4) | ||||
aThe AAPC or ACP has significantly different from zero (P < .05)
Fig. 2The trends of major cancers’ age-standardized mortality rate (ASR) from 1999 to 2016 in Tianjin, China